$2,190.00

NALM6/Cre stable cell line

Catalog number
CL-2226
Description
NALM6/Cre cells are derived from the human precursor B cell lymphoblast cell line NALM6 by stably integration of a constitutive Cre recombinase stably expression construct. NALM6 cells stably express CD19, are ideal for testing CAR T cell or other immunotherapies. NALM6/Cre cells stably express a nuclear localized Cre recombinase.

Product Details

Package Size 2 x 10^6 cells
Parental cell line NALM6 cells
Transgenic gene Cre recombinase
Mammalian selection Puromycin
Biosafety level 2
Storage Liquid nitrogen
Availability 3-4 weeks
Shipping condition dry ice
Copyright © 2024, FenicsBIO. All rights reserved.